Edelweiss Financial Services LimitedNSE: EDELWEISS

Tranche III Prospectus (Final filed with SE)

· Issued by Edelweiss Financial Services Limited

Tranche III Prospectus

June 28, 2023

EDELWEISS FINANCIAL SERVICES LIMITED

Edelweiss Financial Services Limited (the "Company" or "Issuer") was incorporated at Mumbai on November 21, 1995 as a public limited company with the name 'Edelweiss Capital Limited' under the provisions of the Companies Act, 1956. Thereafter, a certificate of commencement of business was issued to our Company by the Registrar Of Companies Maharashtra, at Mumbai, ("RoC"), on January 16, 1996. Subsequently, the name of our Company was changed to 'Edelweiss Financial Services Limited' pursuant to a fresh certificate of incorporation issued by the RoC on August 1, 2011. For more information about our Company, please refer "General Information" and "History and Main Objects" on pages 53 and 162 of the Shelf Prospectus and pages 51 and 143 of this Tranche III Prospectus.

Registered Office: Edelweiss House, Off C.S.T. Road, Kalina, Mumbai 400 098, Maharashtra, India; Tel.: +91 22 4009 4400;

Fax: +91 22 4086 3610; CIN: L99999MH1995PLC094641; PAN: AAACE1461E; Website: www.edelweissfin.com; Email: efslncd@edelweissfin.com Company Secretary and Compliance Officer: Mr. Tarun Khurana; Tel.: +91 22 4009 4400; Email: efslncd@edelweissfin.com

Chief Financial Officer: Ms. Ananya Suneja; Tel: +91 22 4009 4400; Email: efslncd@edelweissfin.com

PUBLIC ISSUE BY THE COMPANY OF SECURED REDEEMABLE NON-CONVERTIBLE DEBENTURES OF FACE VALUE OF ₹ 1,000 EACH ("NCDs") OR "DEBENTURES")

FOR AN AMOUNT OF ₹ 1,500 MILLION ("BASE ISSUE SIZE) WITH AN OPTION TO RETAIN OVERSUBSCRIPTION UP TO ₹ 1,500 MILLION AMOUNTING TO ₹ 3,000 MILLION ("TRANCHE III ISSUE LIMIT") ("TRANCHE III ISSUE") WHICH IS WITHIN THE SHELF LIMIT OF ₹ 10,000 MILLION AND IS BEING OFFERED BY WAY OF THIS TRANCHE III PROSPECTUS DATED JUNE 28, 2023 CONTAINING INTER ALIA THE TERMS AND CONDITIONS OF TRANCHE III ISSUE ("TRANCHE III PROSPECTUS"), WHICH SHOULD BE READ TOGETHER WITH THE SHELF PROSPECTUS DATED DECEMBER 27, 2022 ("SHELF PROSPECTUS") FILED WITH THE ROC, STOCK EXCHANGES AND SECURITIES AND EXCHANGE BOARD OF INDIA ("SEBI"). THE SHELF PROSPECTUS AND TRANCHE III PROSPECTUS CONSTITUTES THE PROSPECTUS ("PROSPECTUS"). THE ISSUE IS BEING MADE PURSUANT TO THE PROVISIONS OF SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE AND LISTING OF NON-CONVERTIBLE SECURITIES) REGULATIONS, 2021, AS AMENDED (THE "SEBI NCS REGULATIONS"), THE COMPANIES ACT, 2013 AND RULES MADE THEREUNDER AS AMENDED TO THE EXTENT NOTIFIED AND THE SEBI OPERATIONAL CIRCULAR. THE ISSUE IS NOT UNDERWRITTEN.

OUR PROMOTERS

  1. Mr. Rashesh Shah; Email: efslncd@edelweissfin.com; Tel: +91 22 4009 4400, (ii) Mr. Venkatchalam Ramaswamy; Email: efslncd @edelweissfin.com; Tel: +91 22 4009 4400, (iii) Ms. Vidya Shah; Email: efslncd@edelweissfin.com; Tel: +91 22 4009 4400, and (iv) Ms. Aparna T.C; Email: efslncd@edelweissfin.com; Tel: +91 22 4009 4400. For details of our Promoters, see "Our Promoter" on page 184 of the Shelf Prospectus.

GENERAL RISKS

For taking an investment decision, investors must rely on their own examination of the Issuer and the Issue, including the risks involved. Specific attention of the Investors is invited to the chapters "Risk Factors" on page 18 of this Tranche III Prospectus, before making an investment in such Issue. This Tranche III Prospectus has not been and will not be approved by any regulatory authority in India, including the Securities and Exchange Board of India ("SEBI"), the Reserve Bank of India ("RBI"), any registrar of companies or any stock exchange in Indian or do they guarantee the accuracy or adequacy of this document.

COUPON RATE, COUPON PAYMENT FREQUENCY, REDEMPTION DATE, REDEMPTION AMOUNT & ELIGIBLE INVESTORS

For details relating to Coupon Rate, Coupon Payment Frequency, Redemption Date, Redemption Amount & Eligible Investors of the NCDs, please refer to the section titled "Issue Related Information" on page 207 of this Tranche III Prospectus.

CREDIT RATING

The NCDs proposed to be issued under the Issue have been rated "CRISIL AA-/Negative (pronounced as CRISIL double A minus rating with Negative outlook)" for an amount of ₹ 10,000 million by CRISIL vide rating letter dated December 02, 2022, revalidated vide their letters dated February 6, 2023 and June 22, 2023 with rating rationale dated December 01, 2022 and June 22, 2023 and "ACUITE AA-/ Negative (pronounced as ACUITE double A minus)" for an amount of ₹ 10,000 million by Acuité vide their rating letter dated December 07, 2022, revalidated vide there letter dated February 13, 2023 and June 14, 2023 with rating rationale dated December 07, 2022. The ratings given by the Credit Rating Agencies are valid as on the date of this Tranche III Prospectus and shall remain valid until the ratings are revised or withdrawn. The rating is not a recommendation to buy, sell or hold securities and investors should take their own decision. The rating may be subject to revision or withdrawal at any time by the assigning rating agency and each rating should be evaluated independently of any other rating. The rating agency has a right to suspend or withdraw the rating at any time on the basis of factors such as new information. These ratings are not a recommendation to buy, sell or hold securities and Investors should take their own decisions. Please refer to Annexure A and Annexure B of this Tranche III Prospectus for the rating letter, rationale, revalidation and press release of the above rating.

LISTING

The NCDs offered through the Draft Shelf Prospectus, the Shelf Prospectus and this Tranche III Prospectus are proposed to be listed on BSE Limited ("BSE") and BSE shall be the Designated Stock Exchange. Our Company has received an 'in-principle' approval from BSE vide their letter no. DCS/BM/PI-BOND/017/22-23 dated December 20, 2022.

PUBLIC COMMENTS

The Draft Shelf Prospectus dated December 12, 2022 was filed with the BSE, pursuant to the provisions of the SEBI NCS Regulations and was kept open for public comments for a period of seven Working Days (i.e., until 5 p.m.) on December 19, 2022. No comments were received on the Draft Shelf Prospectus until 5p.m. on December 19, 2022

LEAD MANAGER TO THE ISSUE

REGISTRAR TO THE ISSUE

DEBENTURE TRUSTEE TO THE ISSUE

EQUIRUS CAPITAL PRIVATE LIMITED

KFIN TECHNOLOGIES LIMITED

BEACON TRUSTEESHIP LIMITED*

12th Floor, C Wing,

Selenium Tower-B,

4 C&D, Siddhivinayak Chambers,

Marathon Futurex, N.M. Joshi Marg,

Plot 31 & 32 Gachibowli,

Gandhi Nagar, Opp. MIG Cricket Club

Lower Parel, Mumbai 400 013

Financial District, Nanakramguda,

Bandra (East), Mumbai 400 051

Tel: +91 22 4332 0736

Serilingampally, Hyderabad - 500 032, Telangana

Tel.: +91 22 26558759

Fax: +91 22 4332 0750

Tel: +91 40 6716 2222

Email: compliance@beacontrustee.co.in

Email: efsl.ncd@equirus.com

Email:efsl3.ncdipo@kfintech.com

Website: www.beacontrustee.co.in

Website: www.equirus.com

Website: www.kfintech.com

Contact Person: Kaustubh Kulkarni

Contact person: Malay Shah

Contact Person: M Murali Krishna

CREDIT RATING AGENCY

STATUTORY AUDITOR

S. R. BATLIBOI & CO. LLP

12th Floor, The Ruby

ACUITÉ RATINGS & RESEARCH LIMITED

CRISIL Ratings Limited

29 Senapati Bapat Marg

Dadar (West),

708, Lodha Supremus,

CRISIL House,

Mumbai 400 028

Lodha iThink Techno Campus,

Central Avenue, Hiranandani Business Park,

Maharashtra, India

Kanjurmarg (East), Mumbai 400 042

Powai, Mumbai 400076

Tel: + 91 22 6819 8000

Tel: + 91 22 4929 4000

Tel: + 91 22 3342 3000

Email: srbc@srb.in

Email: chitra.mohan@acuite.in

Fax: +91 22 4040 5800

Contact Person: Shrawan Jalan

Website: www.acuite.in

Email: crisilratingdesk@crisil.com

Contact Person: Chitra Mohan

Website: www.crisilratings.com

Contact Person: Krishna Sitaraman

TRANCHE III ISSUE PROGRAMME**

TRANCHE III ISSUE OPENS ON: TUESDAY JULY 4, 2023

TRANCHE III ISSUE CLOSES ON: MONDAY JULY 17, 2023

*Beacon Trusteeship Limited under regulation 8 of SEBI NCS Regulations has by its letter dated December 9, 2022 given its consent for its appointment as Debenture Trustee to the Issue and for its name to be included in this Tranche III Prospectus and in all the subsequent periodical communications sent to the holders of the NCDs issued pursuant to the Issue.

  • This Tranche III Issue shall remain open for subscription on Working Days from 10 a.m. to 5 p.m. (Indian Standard Time) during the period indicated above, except that this Tranche III Issue may close on such earlier date or extended date as may be decided by the Board of Directors of our Company or the Debenture Fund Raising Committee. Pursuant to Regulation 33A of the SEBI NCS Regulations, (i) the Tranche III Issue shall be kept open for a minimum of three working days and a maximum of ten working days, (ii) in case of a revision in the price band or yield, the Company shall extend the Tranche III Issue Period for a minimum period of three working days, provided that it shall not exceed the maximum number of days, as provided above in (i), and (iii) in case of force majeure, banking strike or similar circumstances, the Company may, for reasons to be recorded in writing, extend the Tranche III Issue Period, provided that it shall not exceed the maximum number of days, as provided above in (i). In the event of an early closure or extension of this Tranche III Issue, our Company shall ensure that notice of the same is provided to the prospective investors through an advertisement in a daily national newspaper with wide circulation on or before such earlier or initial date of Tranche III Issue closure. On this Tranche III Issue Closing Date, the Application Forms will be accepted only between 10 a.m. and 3 p.m. (Indian Standard Time) and uploaded until 5 p.m. or such extended time as may be permitted by the Stock Exchange. For further details please refer to the section titled "General Information" on page 51.

A copy of this Tranche III Prospectuses shall be filed with the Registrar of Companies, Maharashtra at Mumbai in terms of Section 26 of Companies Act, 2013, along with the endorsed/certified copies of all requisite documents. For further details, please refer to the section titled "Material Contracts and Documents for Inspection" on page 273 of this Tranche III Prospectus.

TABLE OF CONTENTS

SECTION I - GENERAL

3

DEFINITIONS AND ABBREVIATIONS

3

CERTAIN CONVENTIONS, USE OF FINANCIAL, INDUSTRY AND MARKET DATA AND

CURRENCY OF PRESENTATION

15

FORWARD LOOKING STATEMENTS

17

SECTION II - RISK FACTORS

18

SECTION III - INTRODUCTION

51

GENERAL INFORMATION

51

CAPITAL STRUCTURE

61

OBJECTS OF THE ISSUE

69

STATEMENT OF POSSIBLE TAX BENEFITS

72

SECTION IV - ABOUT OUR COMPANY

85

INDUSTRY OVERVIEW

85

OUR BUSINESS

121

MATERIAL DEVELOPMENTS

143

SECTION V - FINANCIAL INFORMATION

154

FINANCIAL STATEMENTS

154

FINANCIAL INDEBTEDNESS

155

SECTION VI - LEGAL AND OTHER INFORMATION

166

OUTSTANDING LITIGATIONS

166

OTHER REGULATORY AND STATUTORY DISCLOSURES

191

SECTION VII - ISSUE RELATED INFORMATION

207

ISSUE STRUCTURE

207

TERMS OF THE ISSUE

215

ISSUE PROCEDURE

235

MATERIAL CONTRACTS AND DOCUMENTS FOR INSPECTION

273

DECLARATION

276

ANNEXURE A - CRISIL RATING, RATING RATIONALE, PRESS RELEASE AND

REVALIDATION LETTER

277

ANNEXURE B - ACUITE RATING, RATING RATIONALE, PRESS RELEASE AND

REVALIDATION LETTER

278

ANNEXURE C - DEBENTURE TRUSTEE CONSENT LETTER

279

ANNEXURE D - ILLUSTRATIVE CASHFLOWS

280

2

SECTION I - GENERAL

DEFINITIONS AND ABBREVIATIONS

This Tranche III Prospectus uses certain definitions and abbreviations which, unless the context otherwise indicates or implies, shall have the meaning ascribed to such definitions and abbreviations set forth herein. References to any legislation, act, regulation, rules, guidelines, clarifications or policies shall be to such legislation, act, regulation, rules, guidelines, clarifications or policies as amended, supplemented or re-enacted from time to time until the date of this Tranche III Prospectus, and any reference to a statutory provision shall include any subordinate legislation notified from time to time pursuant to such provision.

The words and expressions used in this Tranche III Prospectus but not defined herein shall have, to the extent applicable, the same meaning ascribed to such words and expressions under the SEBI NCS Regulations, the Companies Act, 2013, the SCRA, the Depositories Act and the rules and regulations notified thereunder.

General Terms

Term

Description

Associates

Associate would mean associates of our Company as at and for the relevant

financial year/period as applicable.

"EFSL" or "Company" or

Edelweiss Financial Services Limited, a public limited company incorporated

"the Issuer"

under the Companies Act, 1956, and having its Registered Office at Edelweiss

House, Off C.S.T. Road, Kalina, Mumbai 400 098, Maharashtra, India.

"we" or "us" or "our"

Unless the context otherwise requires, this refers to Edelweiss Financial Services

Limited together with its Subsidiaries, Associates and Trusts for the relevant

financial year/period as applicable.

Subsidiaries

Subsidiary would mean subsidiaries of our Company as at and for the relevant

financial year/period as applicable. For the details of the subsidiaries of our

Company, as on March, 31, 2023, see "Material Developments - History and Main

Objects" on page 143 of this Tranche III Prospectus.

Trusts

Trust would mean trusts of our Company as at and for the relevant financial

year/period as applicable. For the details of the trusts of our Company, as on March

31, 2023, see "Material Developments - History and Main Objects" on page 143 of

this Tranche III Prospectus.

Company Related Terms

Term

Description

Articles or Articles of

Articles of Association of our Company

Association or AOA

Audit Committee

Audit committee of the Board of Directors

Auditors or Statutory

The current statutory auditors of our Company, M/s. S. R. Batliboi & Co. LLP,

Auditors

Chartered Accountants

Board or Board of

Board of Directors of our Company or any duly constituted committee thereof.

Directors or our Board or

our Board of Directors

Corporate Social

Corporate Social Responsibility Committee of the Board of Directors

Responsibility Committee

Committee

A committee constituted by the Board, from time to time.

Debenture Fund Raising

Debenture Fund Raising Committee as constituted by the Board of Directors

Committee

Directors

Directors of the Company

Equity Shares

Equity shares of the Company of face value of ₹ 1 each

ESOPs

Employee stock options

Independent Director(s)

The independent director(s) on our Board, in terms of Section 2(47) and Section

149(6) of the Companies Act, 2013 and SEBI Listing Regulations

KMP / Key Managerial

Key managerial personnel of our Company as disclosed in the Shelf Prospectus

Personnel

and this Tranche III Prospectus and appointed in accordance with Key Managerial

Personnel, as defined under Section 2(51) of the Companies Act, 2013.

3

Term

Description

LAP

Loan against property

"MoA" or "Memorandum"

Memorandum of Association of our Company

or "Memorandum of

Association"

Nomination and

Nomination and Remuneration Committee of the Board of Directors

Remuneration Committee

Networth

As defined in Section 2(57) of the Companies Act, 2013, as follows:

"Networth means the aggregate value of the paid-up share capital and all reserves

created out of the profits, securities premium account and debit or credit balance

of profit and loss account, after deducting the aggregate value of the accumulated

losses, deferred expenditure and miscellaneous expenditure not written off, as per

the audited balance sheet but does not include reserves created out of revaluation

of assets, write back of depreciation and amalgamation."

Preference Shares

Preference Shares of the Company having face value of ₹5 each.

Promoter Group

Includes such persons and entities constituting the promoter group of our Company

pursuant to Regulation 2 (1) (pp) of the SEBI ICDR Regulations, 2018.

Promoters or our Promoter

The promoters of our Company are Mr. Rashesh Shah, Mr. Venkatchalam

Ramaswamy, Ms. Vidya Shah and Ms. Aparna T.C.

Public Issue 1

Public issue of secured redeemable non-convertible debentures of face value

₹1,000 each aggregating to ₹2,000 million pursuant to the prospectus dated

December 17, 2020.

Public Issue 2

Public issue of secured redeemable non-convertible debentures of face value

₹1,000 each aggregating to ₹4,000 million pursuant to the prospectus dated March

26, 2021.

Public Issue 3

Public issue of secured redeemable non-convertible debentures of face value

₹1,000 each aggregating to ₹ 4,000 million pursuant to the prospectus dated

August 9, 2021.

Public Issue 4

Public issue of secured redeemable non-convertible debentures of face value

₹1,000 each aggregating to ₹ 5,000 million pursuant to the tranche I prospectus

dated November 29, 2021.

Public Issue 5

Public issue of secured redeemable non-convertible debentures of face value

₹1,000 each aggregating to ₹ 4,000 million pursuant to the tranche II Prospectus

dated September 26, 2022.

Public Issue 6

Public issue of secured redeemable non-convertible debentures of face value

₹1,000 each aggregating to ₹ 4,000 million pursuant to the tranche I prospectus

dated December 27, 2022.

Public Issue 7

Public issue of secured redeemable non-convertible debentures of face value

₹1,000 each aggregating to ₹ 4,000 million pursuant to the tranche II prospectus

dated March 31, 2023.

Reformatted Financial

Reformatted Consolidated Financial Information and Reformatted Standalone

Information

Financial Information.

Reformatted Consolidated

The reformatted consolidated statement of assets and liabilities as at March 31,

Financial Information

2023, March 31, 2022, March 31, 2021, the reformatted consolidated statement of

profit and loss for the year ended 2023, 2022, 2021, the reformatted consolidated

statement of cash flows for the year ended 2023, 2022, 2021, the reformatted

consolidated statement of changes in equity for the year ended 2023, 2022, 2021.

Our audited consolidated financial statements as at and for the year ended March

31, 2023, March 31, 2022 and March 31, 2021 form the basis of such reformatted

Consolidated Financial Information.

Reformatted Standalone

The reformatted standalone statement of assets and liabilities of our Company as

Financial Information

at March 31, 2023, March 31, 2022, March 31, 2021, the reformatted standalone

statement of profit and loss for the year ended 2023, 2022, 2021, the reformatted

standalone statement of cash flows for the year ended 2023, 2022, 2021, the

reformatted standalone statement of changes in equity for the year ended 2023,

2022, 2021.

4

Term

Description

Our audited standalone financial statements as at and for the year ended March 31,

2023, March 31, 2022, and March 31, 2021 form the basis of such reformatted

Standalone Financial Information.

Registered Office

The registered office of our Company is situated at Edelweiss House, Off C.S.T.

Road, Kalina, Mumbai 400 098, Maharashtra, India.

Risk Committee

Risk Committee of the Board of Directors.

RoC/ Registrar of

Registrar of Companies, Maharashtra at Mumbai.

Companies

Shareholders

The holders of the Equity Shares from time to time.

Stakeholders' Relationship

Stakeholders' Relationship Committee as constituted by the Board of Directors.

Committee

Total Borrowing(s)/ Total

Debt securities plus borrowings (other than debt securities), subordinated

Debt

liabilities and deposits.

ZGIL

Zuno General Insurance Company (formerly known as Edelweiss General

Insurance Company)

Issue Related Terms

Term

Description

Abridged Prospectus

A memorandum containing the salient features of the Shelf Prospectus and this

Tranche III Prospectus.

Acknowledgement Slip/

The slip or document issued by the Designated Intermediary to an Applicant as

Transaction Registration

proof of registration of the Application Form.

Slip/ TRS

Acuité/ Acuite

Acuité Ratings & Research Limited.

Allotment Advice

The communication sent to the Allottees conveying the details of NCDs allotted to

the Allottees in accordance with the Basis of Allotment.

"Allotment", "Allot" or

Unless the context otherwise requires, the allotment of NCDs to the successful

Allotted

Applicants pursuant to the Tranche III Issue.

Allottee(s)

The successful Applicant to whom the NCDs are Allotted either in full or part,

pursuant to the Tranche III Issue.

"Applicant" or "Investor"

Any person who applies for issuance and Allotment of NCDs through ASBA

process or through UPI Mechanism pursuant to the terms of the Shelf Prospectus,

this Tranche III Prospectus, the Abridged Prospectus and the Application Form.

"Application" or "ASBA

An application (whether physical or electronic) to subscribe to the NCDs offered

Application"

pursuant to the Tranche III Issue by submission of a valid Application Form and

authorising an SCSB to block the Application Amount in the ASBA Account or to

block the Application Amount using the UPI Mechanism, where the Bid Amount

will be blocked upon acceptance of UPI Mandate Request by retail investors for

an Application Amount of upto ₹ 500,000 which will be considered as the

application for Allotment in terms of the Shelf Prospectus and this Tranche III

Prospectus.

Application Amount

The aggregate value of the NCDs applied for, as indicated in the Application Form

for this Tranche III Issue.

Application Form / ASBA

Form in terms of which an Applicant shall make an offer to subscribe to NCDs

Form

through the ASBA process or through the UPI Mechanism and which will be

considered as the Application for Allotment of NCDs in terms of the Shelf

Prospectus and this Tranche III Prospectus.

ASBA Account

An account maintained with a SCSB and specified in the Application Form which

will be blocked by such SCSB to the extent of the Application Amount mentioned

in the Application Form by an Applicant and will include a bank account of a retail

individual investor linked with UPI, for retail individual investors submitting

application value upto ₹ 500,000.

Banker(s) to the Issue

Collectively Public Issue Account Bank, Refund Bank and Sponsor Bank.

Base Issue Size

₹ 1,500 million

Basis of Allotment

The basis on which NCDs will be allotted to applicants under specified in this

Tranche III Prospectus for Tranche III Issue and which is described in "Issue

Procedure - Basis of Allotment" on page 269 of this Tranche III Prospectus.

5

This is an excerpt of the original content. To continue reading it, access the original document here.